You are here

Annu Rev Med DOI:10.1146/annurev-med-060712-200152

DNA sequencing of cancer: what have we learned?

Publication TypeJournal Article
Year of Publication2014
AuthorsChmielecki, J, Meyerson, M
JournalAnnu Rev Med
Volume65
Pages63-79
Date Published2014
ISSN1545-326X
KeywordsCell Cycle, DNA Mutational Analysis, Epigenesis, Genetic, Gene Rearrangement, Humans, Mitogen-Activated Protein Kinases, Neoplasms, Oncogene Fusion, Oncogene Protein v-akt, RNA, Signal Transduction, Transcription Factors, Transcription, Genetic
Abstract

DNA sequencing has taught us much about the structure of cancer genomes and enabled the discovery of novel genes that drive and maintain tumorigenesis. With the advent and application of next-generation massively parallel sequencing technologies, one can rapidly generate and analyze data from the cellular "-omes": genomes, exomes, and transcriptomes. This review highlights recent genomic discoveries in signal transduction, metabolism, epigenetic modifications, cell cycle and genome maintenance, RNA processing, and transcription. Additionally, genomic sequencing has revealed the complexity of the cancer genome and has enabled the discovery of functional rearrangements with therapeutic and diagnostic potentials.

URLhttp://arjournals.annualreviews.org/doi/full/10.1146/annurev-med-060712-200152?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
DOI10.1146/annurev-med-060712-200152
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/24274178?dopt=Abstract

Alternate JournalAnnu. Rev. Med.
PubMed ID24274178